JOST Werke (JST) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
29 Mar, 2026Executive summary
Achieved strong profitable growth in 2025, driven by the successful and efficient integration of Hyva, organic gains, and the divestment of the non-core Cranes business, despite global economic volatility and challenging market conditions, particularly in North America.
Gained market share through new customer projects, leveraging a local-for-local approach and global strength, with all regions and business lines contributing to growth, especially in agriculture.
Diversification across industries, customers, and regions enhanced resilience and profitability.
Robust order intake in Q1 2026 with visible recovery across all business lines and regions.
Set new CO2 reduction targets, aiming for a further 50% reduction per production hour by 2035 compared to 2025.
Financial highlights
Sales from continuing operations rose 44% to approximately EUR 1.5 billion in 2025, including EUR 468.0 million from Hyva, with organic growth of 2%.
Adjusted EBIT increased by 29% to EUR 145 million, with a margin of 9.5%; adjusted EBITDA up 29.1% to EUR 191.2 million.
Adjusted net income from continuing operations up 12% to EUR 84 million; adjusted EPS up 11% to EUR 5.52.
Free cash flow reached a record EUR 126 million, up 6%.
Leverage at 2.27x EBITDA, below the 2.5x target, despite debt-financed Hyva acquisition.
Outlook and guidance
2026 guidance: single-digit sales growth, mid to high single-digit Adjusted EBIT growth, and margin improvement, supported by further Hyva synergies.
CapEx expected at 2.8% of sales; working capital projected between 17.5%-18.5% of sales.
Guidance includes negative FX effects; upside potential from U.S. market recovery and EPA 2027 pre-buy, downside from Iran conflict and energy costs.
Dividend proposal of EUR 1.50 per share, or 30% of adjusted net income.
Hyva PMI to conclude in 2026, with remaining synergies targeted by Q4 2026.
Latest events from JOST Werke
- Sales up 12.1% and EBIT up 21% in H1 2026, with improved leverage and strong outlook.JST
Q2 2026 - Record Q1 2026 sales and margin gains, driven by Hyva synergies and organic growth.JST
Q1 2026 - Strong 2025 growth, digital innovation, and Hyva integration drive ambitious 2030 targets.JST
Investor presentation - Acquisition targets EUR 23–28m synergies, expands global reach, and closes in Q4 2024.JST
M&A Announcement - Profitability and cash flow remained strong despite sales declines, with key acquisitions advancing.JST
Q3 2024 - Acquisitions and expansion add €100m in sales and boost agricultural market reach.JST
Investor Update - Targets €2B+ sales, €10 EPS, and 10–12% EBIT margin by 2030, driven by innovation and M&A.JST
CMD 2024 - Margins and cash flow improved despite sales decline; 2024 guidance confirmed.JST
Q2 2024 - Hyva acquisition to drive 50–60% sales growth and margin expansion in 2025.JST
Q4 2024